GAMMA Investing’s Bioventus BVS Stock Holding History

GAMMA Investing’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$50.6K	Buy	3,716 +583	+19%	+$7.68K	﹤0.01%	2359
2026 Q2	$29.6K	Buy	3,133 +74	+2%	+$707	﹤0.01%	2624
2026 Q1	$27.9K	Buy	3,059 +1,105	+57%	+$9.27K	﹤0.01%	2534
2025 Q4	$14.5K	Buy	1,954 +693	+55%	+$4.98K	﹤0.01%	2789
2025 Q3	$8.44K	Buy	1,261 +807	+178%	+$5.6K	﹤0.01%	2962
2025 Q2	$3K	Sell	454 -179	-28%	-$1.27K	﹤0.01%	3284
2025 Q1	$5.79K	Buy	633 +459	+264%	+$4.58K	﹤0.01%	3026
2024 Q4	$1.83K	Buy	174 +104	+149%	+$1.23K	﹤0.01%	3246
2024 Q3	$837	Buy	+70	New	+$605	﹤0.01%	3299

Other funds holding BVS

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's BVS Position: Q3 2026 in Review

GAMMA Investing increased its Bioventus (BVS) stake by 19% in Q3 2026, buying an estimated $7.68K and bringing the position to 3,716 shares worth $50.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

GAMMA Investing first reported a position in BVS in Q3 2024 and has held it in 9 quarters since. 3 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

GAMMA Investing held 3,716 shares of Bioventus worth $50.6K as of Q3 2026.
GAMMA Investing bought 583 Bioventus shares in Q3 2026, an estimated $7.68K.
Bioventus made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2359 holding.
GAMMA Investing first reported a position in Bioventus in Q3 2024 and has held it in 9 quarters since.
3 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.